|The Bacillus anthracis n/a (Catalog #MBS531435) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Bacillus anthracis (Anthrax) antibody (Spore) reacts with Bacillus anthracis and may cross-react with other species as described in the data sheet. MyBioSource\'s Bacillus anthracis can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB). Researchers should empirically determine the suitability of the Bacillus anthracis n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal Bacillus anthracis (Anthrax) antibody (Spore).
Biological Significance: Bacillus anthracis is a Gram-positive spore-forming, rod-shaped bacterium, with a width of 1-1.2 um and a length of 3-5 um. It can be grown in an ordinary nutrient medium under aerobic or anaerobic conditions. It is the only bacterium known to synthesize a protein capsule (D-glutamate), and the only pathogenic bacterium to carry its own adenylyl cyclase virulence factor (edema factor). Biohazard Information: This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
Immunogen: Bacillus anthracis (anthrax) antibody was raised in mouse using Bacillus anthracis spore extract as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Bacillus anthracis are readily searchable from our website. Different antibodies against the same target such as Bacillus anthracis may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.